In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.Gregory P. Dubé, W L Kurtz, Joseph A. Jakubowski et al.|Journal of Pharmacology and Experimental Therapeutics|1995Cited by 3
03 Affymetrix gene chip analysis of differentially expressed genes in rat post MI CHF modelJian Wang, Michael E. Christe, Guerry Cook et al.|Journal of Molecular and Cellular Cardiology|2002Cited by 2